Announcement • May 12
Atlas Metals Group plc, Annual General Meeting, Jun 03, 2026 Atlas Metals Group plc, Annual General Meeting, Jun 03, 2026. Location: the offices of orrick, herrington and sutcliffe uk llp, 107 cheapside, ec2v 6dn, london United Kingdom New Risk • Apr 19
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Negative equity (-UK£5.0m). Earnings have declined by 19% per year over the past 5 years. Shareholders have been substantially diluted in the past year (165% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (UK£2.61m market cap, or US$3.52m). Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Announcement • Mar 05
Atlas Metals Group plc announced that it expects to receive £2.375 million in funding from Yorkville Advisors Global LP Atlas Metals Group plc announced a private placement and entered into an agreement with A II PN Ltd, an institutional investor managed by Yorkville Advisors Global, LP for a convertible loan of £2,500,000 on March 5, 2026. The Funding Facility is made up of two convertible loans, a first loan of £500,000 and a second loan of up to £2,000,000. The First Loan is expected to be provided to the Company following satisfaction of certain customary conditions precedent and will be advanced net of fees and a 5% original issue discount on satisfaction of those conditions for payment. The Lender may, at any time for so long as any amount is outstanding under the Funding Facility, elect to convert amounts outstanding under the Loans into new ordinary shares in the Company at a conversion price equal to 120% of the closing price of the Ordinary Shares on the trading day immediately prior to the Completion Date. Conversion is subject to certain customary scaling-back provisions, which prevent the Lender from holding more than 29.99% of the Company upon conversion. The First Loan has a maturity of 104 days from the Completion Date and will be repaid by way of monthly amortization over that period, unless the Lender has exercised its conversion rights under the Funding Facility. The First Loan carries interest at 5% per annum, accruing from the Completion Date and calculated on a daily basis. The Second Loan of up to £2,000,000 will be available for drawdown subject to the satisfaction of certain conditions. These conditions include the Company having made two consecutive monthly repayments in respect of the First Loan, a minimum median average daily trading value of £50,000 over the preceding 60 trading days, and the closing price of the Ordinary Shares being above the Conversion Price. The Second Loan will be subject to deductions comprising a 5% original issue discount, a 1% commitment fee, and an amount to repay any outstanding balance of the First Loan. Repayment of the Second Loan will be by way of monthly amortization over a period of approximately 11 months, commencing 60 days after drawdown, unless the Lender has previously exercised its conversion rights. The Second Loan carries interest at 5% per annum accruing from the date that the Second Loan is drawn down by the Company and calculated on a daily basis. Pursuant to the Funding Facility, the Company has entered into the Warrant Agreement with the Lender, pursuant to which the Company will issue to the Lender warrants equal to 25% of each monthly amortization payment amount ("Warrants"), with an exercise price equal to 115% of the closing price of the Ordinary Shares on the date that the First Loan is provided to the Company. The Warrants will expire three years after issue. The Company may require the Warrants to be exercised if the Ordinary Shares trade at least 30% above the warrant exercise price for 20 consecutive trading days. The aggregate subscription price payable on exercise of the Warrants may be set off by the Lender against the outstanding balance of the Loans. Announcement • Feb 11
Atlas Metals Group plc Provides an Update on the Company's Interest in the Kamushanovskoye Uranium Deposit Atlas Metals provided an update on the Company's interest in the Kamushanovskoye uranium deposit, located in northern Kyrgyzstan, 48km northeast of the capital of the Kyrgyz Republic, Bishkek. The Project is owned by International Mining Company Invest Inc. and currently Atlas Metals has a 10% interest in IMC. At the time Atlas Metals invested in the Project in 2018, the in-situ value of contained uranium totalled USD 151 million at a uranium price of USD 27-28/lb. Over the last six months, the uranium price has reached USD 80-85/lb, placing a value of approximately USD 700 million on the contained resources. The Project has been under exploration since 2011 and the State Reserve Committee of Kyrgyzstan granted an application for a mining licence in January 2019 for 3,371.1 tonnes of uranium reserves (8.731 million lbs U3O8). This provides an in-situ value of approximately USD 700 million at a uranium price of USD 80-85/lb. In May 2019, the Kyrgyz parliament voted to ban uranium mining in the country and the Mining Licence was cancelled without any compensation. IMC contested this action and appealed the decision under international arbitration. Hearings were held in 2024-25 and a decision is in process (case ICSID ARB/22/25). The Parliament of Kyrgyzstan approved a bill lifting the ban on prospecting, exploration, development and mining of uranium and thorium in the Kyrgyz Republic in June 2024. As part of the work completed since the grant of the Mining Licence and to support IMC's case at arbitration, a detailed review and assessment of the Project took place and was completed in 2024. The review was completed by Dr Mike Armitage, BSc, MIMMM, FGS, CEng, CGeol and confirmed both the potential viability of the extraction method as well as the resource estimate approved by GKZ. The deposit is uranium oxide hosted in peat soils at depths from surface down to a maximum of 14 metres. Testwork on site of in-situ recovery confirmed good extraction of uranium using sodium carbonate as the leaching solution. In-situ recovery comprises the injection of the leaching solution into the site and recovering the pregnant solution using shallow pump wells. The pregnant solution can be enhanced on site to a product than can be shipped for final processing. Due to the shallow depths and simple technology, the operating and capital costs are low. Discussions are underway with possible development partners and the Kyrgyz government to find a satisfactory conclusion for all parties. Announcement • Feb 04
Atlas Metals Group plc has filed a Follow-on Equity Offering. Atlas Metals Group plc has filed a Follow-on Equity Offering.
Security Name: Ordinary Shares
Security Type: Common Stock
Transaction Features: At the Market Offering New Risk • Dec 21
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 63% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£1.3m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Negative equity (-UK£5.0m). Earnings have declined by 19% per year over the past 5 years. Shareholders have been substantially diluted in the past year (63% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (UK£2.83m market cap, or US$3.79m). 